A former Donald Trump insider and MAGA leader on Saturday called out the administration's newest reported health moves, employing a five-word question.Marjorie A former Donald Trump insider and MAGA leader on Saturday called out the administration's newest reported health moves, employing a five-word question.Marjorie

MAGA leader levels Trump agency's new move with a five-word question

2026/02/22 09:00
1 min read

A former Donald Trump insider and MAGA leader on Saturday called out the administration's newest reported health moves, employing a five-word question.

Marjorie Taylor Greene, previously a strong ally of the president including in his second term, broke with the admin when it came to the fight to release files related to convicted child sex abuser Jeffrey Epstein. Over the weekend, she weighed in on a report about Trump's FDA.

Specifically, The Guardian reported, "Trump FDA retreats from plan to ban artificial colors in food."

Commenting on Leading Report's post, "BREAKING: Trump FDA retreats from plan to ban artificial colors in food, per The Guardian," Greene chimed in with a simple question.

"What level chess is this?" the ex-lawmaker asked.

Greene was referring to a common claim from Trump's supporters that the president is constantly engaged in "4-D chess" while everyone else is playing checkers. Instead of outsmarting everyone, Greene implied the administration had fumbled the health policy.

Market Opportunity
OFFICIAL TRUMP Logo
OFFICIAL TRUMP Price(TRUMP)
$3.424
$3.424$3.424
-2.83%
USD
OFFICIAL TRUMP (TRUMP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.